Back to Search
Start Over
Phase II trial of homoharringtonine with imatinib in chronic, accelerated, and blast phase chronic myeloid leukemia.
- Source :
-
Leukemia & lymphoma [Leuk Lymphoma] 2017 Sep; Vol. 58 (9), pp. 1-6. Date of Electronic Publication: 2017 Feb 09. - Publication Year :
- 2017
- Subjects :
- Adult
Aged
Antineoplastic Combined Chemotherapy Protocols adverse effects
Blast Crisis
Female
Harringtonines administration & dosage
Homoharringtonine
Humans
Imatinib Mesylate administration & dosage
Leukemia, Myelogenous, Chronic, BCR-ABL Positive mortality
Leukemia, Myeloid, Accelerated Phase
Leukemia, Myeloid, Chronic-Phase
Male
Middle Aged
Neoplasm Staging
Retreatment
Treatment Outcome
Young Adult
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive pathology
Subjects
Details
- Language :
- English
- ISSN :
- 1029-2403
- Volume :
- 58
- Issue :
- 9
- Database :
- MEDLINE
- Journal :
- Leukemia & lymphoma
- Publication Type :
- Report
- Accession number :
- 28278723
- Full Text :
- https://doi.org/10.1080/10428194.2017.1283030